SOLVAY ANALYSTS & INVESTORS DAY October 4, 2005 Solvay group : focus on Growth, Competitiveness and renewal M. A. Michielsen, CEO of the Solvay group Focus on Growth, Competitiveness and asylum Solvay : a interbreeding stem with 3 sectors Our Transformation Our blind for the future Solvay Analysts and Investors Day 2 October 4, 2005 © 2005, SOLVAY S.A. N.V. SOLVAY TODAY A cross group with 3 sectors : Chemicals, P stopping pointics and pharmaceuticals Major TRANSFORMATIONAL portfolio reshuffling everyplace the last 10 years resulting in LOWER CYCLICALITY Strategy for product A clear focus on sustainable and utile GROWTH in selected areas of pharmaceuticals, chemicals and plastics innovation is our cornerstone to turn in growth and to ensure competitiveness Building the next Solvay drug companyceuticals Unlocking resources to consequence Chemicals growth Enrichment of Plastics portfolio and regrouping of our forces Solvay Analysts and Investors Day 3 October 4, 2005 © 2005, SOLVAY S.A. N.V.
Solvay Today A mark GROUP with 3 sectors (1) Pharmaceuticals In % of gross revenue1 Chemicals Plastics In % of REBIT2 22% 29% 31% 22% 47% 49% 2004 : before the eruditeness of Fournier Pharma (sales : EUR 593 M, REBIT : EUR 138 M) 1 Total 2004 Sales = EUR 7,877 M, including also discontinuing trading operations for EUR 67 M 2 Total 2004 REBIT = EUR 789 M, including also discontinuing operations and non allocated items, respectively EUR 25 M and EUR -49 M Solvay Analysts and Investors Day 4 October 4, 2005 © 2005, SOLVAY S.A. N.V. Sol vay Today A HYBRID GROUP with 3 sectors (! 2) REBIT/Sales 14% Chemicals 12% Plastics Chemicals assort 10% Pharmaceuticals 8% Group Plastics Pharmaceuticals 6% 4% 2% 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 H1/05 2004 : before the acquisition of Fournier Pharma (sales : EUR 593 M, REBIT : EUR 138 M) 1 Total 2004 Sales = EUR 7,877 M, including also...
If you want to get a full essay, order it on our website: OrderCustomPaper.com
If you want to get a full essay, visit our page: write my paper< /a>
No comments:
Post a Comment